Pines Wealth Management’s AbbVie ABBV Stock Holding History

Pines Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.97M	Sell	7,526 -282	-4%	-$72.3K	0.56%	40
2026 Q2	$1.96M	Buy	7,808 +201	+3%	+$43.2K	0.57%	38
2026 Q1	$1.65M	Buy	7,607 +594	+8%	+$132K	0.54%	44
2025 Q4	$1.6M	Buy	7,013 +445	+7%	+$101K	0.52%	47
2025 Q3	$1.52M	Sell	6,568 -65	-1%	-$13.2K	0.51%	43
2025 Q2	$1.26M	Buy	6,633 +853	+15%	+$159K	0.44%	54
2025 Q1	$1.02M	Buy	5,780 +117	+2%	+$22.7K	0.47%	58
2024 Q4	$992K	Buy	+5,663	New	+$1.04M	0.43%	58

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Pines Wealth Management's ABBV Position: Q3 2026 in Review

Pines Wealth Management reduced its AbbVie (ABBV) stake by 3.6% in Q3 2026, selling an estimated $72.3K and leaving 7,526 shares worth $1.97M. The position accounts for 0.56% of the portfolio, ranked #40.

Pines Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Pines Wealth Management held 7,526 shares of AbbVie worth $1.97M as of Q3 2026.
Pines Wealth Management sold 282 AbbVie shares in Q3 2026, an estimated $72.3K.
AbbVie made up 0.56% of Pines Wealth Management's portfolio in Q3 2026, its #40 holding.
Pines Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Pines Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.